Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock

J Antimicrob Chemother. 2002 Jan;49(1):193-6. doi: 10.1093/jac/49.1.193.

Abstract

The efficacy of two polymyxin-like peptides, KFFKFFKFF and IKFLKFLKFL, alone and combined with levofloxacin, was investigated in a rat model of septic shock. Rats were given an ip injection of 2 x 10(10) cfu of Escherichia coli and randomized to receive ip isotonic sodium chloride solution, 7 mg/kg levofloxacin, 1 mg/kg polymyxin B and 1 mg/kg of each polymyxin-like peptides alone or combined with 7 mg/kg levofloxacin. Polymyxins achieved a significant reduction in plasma endotoxin and tumour necrosis factor alpha (TNF-alpha) concentration. Levofloxacin significantly reduced the bacterial growth and TNF-alpha concentration. The combinations of polymyxin-like peptides and levofloxacin demonstrated the highest efficacy.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Infective Agents / therapeutic use
  • Disease Models, Animal*
  • Drug Therapy, Combination / therapeutic use*
  • Injections, Intraperitoneal
  • Levofloxacin*
  • Male
  • Ofloxacin / therapeutic use*
  • Polymyxin B / therapeutic use*
  • Rats
  • Rats, Wistar
  • Shock, Septic / blood
  • Shock, Septic / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Levofloxacin
  • Ofloxacin
  • Polymyxin B